ResearcherOregon Health & Science UniversityNo recent work listed

Shay Behrens

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8676-2345; OpenAlex author ID A5042342189. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2023: 2 papers

Papers 2

Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. Co-author DOI 10.1002/jso.27281 ↗
High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2023.02.012 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Brett C. Sheppard · 2 shared papers, 2023 · strength 0.36
- Paper High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. DOI 10.1016/j.amjsurg.2023.02.012 ↗
- Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281 ↗
Thomas Lee Sutton · 2 shared papers, 2023 · strength 0.36
- Paper High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. DOI 10.1016/j.amjsurg.2023.02.012 ↗
- Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281 ↗
Ranish K. Patel · 2 shared papers, 2023 · strength 0.36
- Paper High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. DOI 10.1016/j.amjsurg.2023.02.012 ↗
- Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281 ↗
Aaron J. Grossberg · 1 shared paper, 2023 · strength 0.17
- Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281 ↗
Skye C. Mayo · 1 shared paper, 2023 · strength 0.17
- Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281 ↗
Charles D. Lopez · 1 shared paper, 2023 · strength 0.17
- Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.